View Past PerformanceOption バランスシートの健全性財務の健全性 基準チェック /16Optionの総株主資本は€681.0K 、総負債は€1.9Mで、負債比率は285.2%となります。総資産と総負債はそれぞれ€9.6Mと€8.9Mです。主要情報285.17%負債資本比率€1.94m負債インタレスト・カバレッジ・レシオn/a現金€443.00kエクイティ€681.00k負債合計€8.89m総資産€9.58m財務の健全性に関する最新情報分析記事 • Oct 09Crescent (EBR:OPTI) Is Carrying A Fair Bit Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...すべての更新を表示Recent updatesNew Risk • Jul 28New major risk - Negative shareholders equityThe company has negative equity. Total equity: -€2.7m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Negative equity (-€2.7m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (€11.6m market cap, or US$13.3m).New Risk • May 29New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 27% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€2.7m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (€14.2m market cap, or US$16.5m).Board Change • May 08Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Non-Executive Independent Director Luc Boedt was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.New Risk • Apr 07New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-€2.7m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€11.0m market cap, or US$12.6m).分析記事 • Feb 13Investors Give Option NV (EBR:OPTI) Shares A 27% HidingTo the annoyance of some shareholders, Option NV ( EBR:OPTI ) shares are down a considerable 27% in the last month...New Risk • Jan 20New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €19.9k (US$23.4k) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€3.7m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Negative equity (-€2.7m). Market cap is less than US$10m (€19.9k market cap, or US$23.4k).分析記事 • Dec 16Take Care Before Jumping Onto Crescent NV (EBR:OPTI) Even Though It's 29% CheaperThe Crescent NV ( EBR:OPTI ) share price has softened a substantial 29% over the previous 30 days, handing back much of...New Risk • Sep 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.38m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€3.7m free cash flow). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Negative equity (-€2.7m). Market cap is less than US$10m (€8.38m market cap, or US$9.80m).分析記事 • Sep 25Crescent NV's (EBR:OPTI) Subdued P/S Might Signal An OpportunityCrescent NV's ( EBR:OPTI ) price-to-sales (or "P/S") ratio of 0.8x may look like a pretty appealing investment...お知らせ • Aug 21Crescent NV to Report First Half, 2025 Results on Sep 19, 2025Crescent NV announced that they will report first half, 2025 results on Sep 19, 2025New Risk • May 05New major risk - Negative shareholders equityThe company has negative equity. Total equity: -€1.1m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€3.5m free cash flow). Share price has been highly volatile over the past 3 months (8.5% average weekly change). Negative equity (-€1.1m). Earnings have declined by 1.7% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.8m market cap, or US$14.5m).New Risk • Apr 08New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.1% average weekly change). Earnings have declined by 2.3% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€12.8m market cap, or US$13.9m).New Risk • Nov 07New major risk - Revenue and earnings growthEarnings have declined by 2.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 2.3% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€20.7m market cap, or US$22.3m).分析記事 • Oct 09Shareholders Should Be Pleased With Crescent NV's (EBR:OPTI) PriceCrescent NV's ( EBR:OPTI ) price-to-sales (or "P/S") ratio of 1.9x may not look like an appealing investment...分析記事 • Jun 21Crescent NV's (EBR:OPTI) Share Price Matching Investor OpinionWhen you see that almost half of the companies in the Communications industry in Belgium have price-to-sales ratios (or...Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent Director Paul Matthijs was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.お知らせ • Apr 26Crescent NV to Report Fiscal Year 2023 Results on May 28, 2024Crescent NV announced that they will report fiscal year 2023 results on May 28, 2024分析記事 • Sep 27Not Many Are Piling Into Crescent NV (EBR:OPTI) Stock Yet As It Plummets 36%The Crescent NV ( EBR:OPTI ) share price has fared very poorly over the last month, falling by a substantial 36%. The...分析記事 • Sep 27It's Down 36% But Crescent NV (EBR:OPTI) Could Be Riskier Than It LooksCrescent NV ( EBR:OPTI ) shareholders that were waiting for something to happen have been dealt a blow with a 36% share...New Risk • Jul 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Belgian stocks, typically moving 8.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (8.3% average weekly change). Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (€39.1m market cap, or US$43.0m).Price Target Changed • Nov 16Price target decreased to €0.03Down from €0.04, the current price target is provided by 1 analyst. New target price is 78% above last closing price of €0.017. Stock is down 32% over the past year. The company posted a net loss per share of €0.003 last year.Price Target Changed • Apr 27Price target decreased to €0.03Down from €0.04, the current price target is provided by 1 analyst. New target price is 51% above last closing price of €0.02. Stock is down 38% over the past year. The company posted a net loss per share of €0.003 last year.Price Target Changed • Mar 31Price target decreased to €0.03Down from €0.04, the current price target is provided by 1 analyst. New target price is 46% above last closing price of €0.021. Stock is down 36% over the past year. The company posted a net loss per share of €0.003 last year.分析記事 • Oct 09Crescent (EBR:OPTI) Is Carrying A Fair Bit Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Reported Earnings • Oct 06First half 2021 earnings released: €0.001 loss per share (vs €0.001 loss in 1H 2020)The company reported a poor first half result with increased losses, weaker revenues and weaker control over costs. First half 2021 results: Revenue: €7.89m (down 13% from 1H 2020). Net loss: €1.40m (loss widened 39% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.分析記事 • Mar 09Should Crescent (EBR:OPTI) Be Disappointed With Their 36% Profit?The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...分析記事 • Nov 24Crescent (EBR:OPTI) Shareholders Have Enjoyed A 22% Share Price GainIt hasn't been the best quarter for Crescent NV (EBR:OPTI) shareholders, since the share price has fallen 20% in that...Reported Earnings • Oct 01First half earnings releasedOver the last 12 months the company has reported total losses of €5.41m, largely unchanged from the prior year. Total revenue was €18.3m over the last 12 months, up 3.2% from the prior year.財務状況分析短期負債: OPTIの 短期資産 ( €3.3M ) は 短期負債 ( €5.7M ) をカバーしていません。長期負債: OPTIの短期資産 ( €3.3M ) が 長期負債 ( €3.2M ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: OPTIの 純負債対資本比率 ( 220.1% ) は 高い と見なされます。負債の削減: OPTIの負債対資本比率は、過去 5 年間で77.9%から285.2%に増加しました。貸借対照表キャッシュ・ランウェイ分析過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。安定したキャッシュランウェイ: OPTIは、現在の フリーキャッシュフロー に基づくと、キャッシュランウェイ が 1 年未満です。キャッシュランウェイの予測: OPTIは、フリーキャッシュフローが毎年29 % の歴史的率で減少し続ける場合、キャッシュランウェイが 1 年未満になります。健全な企業の発掘7D1Y7D1Y7D1YTech 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/16 07:21終値2026/08/14 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Option NV 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Guy SipsKBC Securities NV
分析記事 • Oct 09Crescent (EBR:OPTI) Is Carrying A Fair Bit Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
New Risk • Jul 28New major risk - Negative shareholders equityThe company has negative equity. Total equity: -€2.7m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Negative equity (-€2.7m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (€11.6m market cap, or US$13.3m).
New Risk • May 29New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 27% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€2.7m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Shareholders have been diluted in the past year (27% increase in shares outstanding). Market cap is less than US$100m (€14.2m market cap, or US$16.5m).
Board Change • May 08Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). Non-Executive Independent Director Luc Boedt was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
New Risk • Apr 07New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-€2.7m). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€11.0m market cap, or US$12.6m).
分析記事 • Feb 13Investors Give Option NV (EBR:OPTI) Shares A 27% HidingTo the annoyance of some shareholders, Option NV ( EBR:OPTI ) shares are down a considerable 27% in the last month...
New Risk • Jan 20New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €19.9k (US$23.4k) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€3.7m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Negative equity (-€2.7m). Market cap is less than US$10m (€19.9k market cap, or US$23.4k).
分析記事 • Dec 16Take Care Before Jumping Onto Crescent NV (EBR:OPTI) Even Though It's 29% CheaperThe Crescent NV ( EBR:OPTI ) share price has softened a substantial 29% over the previous 30 days, handing back much of...
New Risk • Sep 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.38m (US$9.80m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€3.7m free cash flow). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Negative equity (-€2.7m). Market cap is less than US$10m (€8.38m market cap, or US$9.80m).
分析記事 • Sep 25Crescent NV's (EBR:OPTI) Subdued P/S Might Signal An OpportunityCrescent NV's ( EBR:OPTI ) price-to-sales (or "P/S") ratio of 0.8x may look like a pretty appealing investment...
お知らせ • Aug 21Crescent NV to Report First Half, 2025 Results on Sep 19, 2025Crescent NV announced that they will report first half, 2025 results on Sep 19, 2025
New Risk • May 05New major risk - Negative shareholders equityThe company has negative equity. Total equity: -€1.1m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€3.5m free cash flow). Share price has been highly volatile over the past 3 months (8.5% average weekly change). Negative equity (-€1.1m). Earnings have declined by 1.7% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€12.8m market cap, or US$14.5m).
New Risk • Apr 08New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.1% average weekly change). Earnings have declined by 2.3% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€12.8m market cap, or US$13.9m).
New Risk • Nov 07New major risk - Revenue and earnings growthEarnings have declined by 2.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 2.3% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€20.7m market cap, or US$22.3m).
分析記事 • Oct 09Shareholders Should Be Pleased With Crescent NV's (EBR:OPTI) PriceCrescent NV's ( EBR:OPTI ) price-to-sales (or "P/S") ratio of 1.9x may not look like an appealing investment...
分析記事 • Jun 21Crescent NV's (EBR:OPTI) Share Price Matching Investor OpinionWhen you see that almost half of the companies in the Communications industry in Belgium have price-to-sales ratios (or...
Board Change • May 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent Director Paul Matthijs was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
お知らせ • Apr 26Crescent NV to Report Fiscal Year 2023 Results on May 28, 2024Crescent NV announced that they will report fiscal year 2023 results on May 28, 2024
分析記事 • Sep 27Not Many Are Piling Into Crescent NV (EBR:OPTI) Stock Yet As It Plummets 36%The Crescent NV ( EBR:OPTI ) share price has fared very poorly over the last month, falling by a substantial 36%. The...
分析記事 • Sep 27It's Down 36% But Crescent NV (EBR:OPTI) Could Be Riskier Than It LooksCrescent NV ( EBR:OPTI ) shareholders that were waiting for something to happen have been dealt a blow with a 36% share...
New Risk • Jul 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Belgian stocks, typically moving 8.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (8.3% average weekly change). Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (€39.1m market cap, or US$43.0m).
Price Target Changed • Nov 16Price target decreased to €0.03Down from €0.04, the current price target is provided by 1 analyst. New target price is 78% above last closing price of €0.017. Stock is down 32% over the past year. The company posted a net loss per share of €0.003 last year.
Price Target Changed • Apr 27Price target decreased to €0.03Down from €0.04, the current price target is provided by 1 analyst. New target price is 51% above last closing price of €0.02. Stock is down 38% over the past year. The company posted a net loss per share of €0.003 last year.
Price Target Changed • Mar 31Price target decreased to €0.03Down from €0.04, the current price target is provided by 1 analyst. New target price is 46% above last closing price of €0.021. Stock is down 36% over the past year. The company posted a net loss per share of €0.003 last year.
分析記事 • Oct 09Crescent (EBR:OPTI) Is Carrying A Fair Bit Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Reported Earnings • Oct 06First half 2021 earnings released: €0.001 loss per share (vs €0.001 loss in 1H 2020)The company reported a poor first half result with increased losses, weaker revenues and weaker control over costs. First half 2021 results: Revenue: €7.89m (down 13% from 1H 2020). Net loss: €1.40m (loss widened 39% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
分析記事 • Mar 09Should Crescent (EBR:OPTI) Be Disappointed With Their 36% Profit?The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...
分析記事 • Nov 24Crescent (EBR:OPTI) Shareholders Have Enjoyed A 22% Share Price GainIt hasn't been the best quarter for Crescent NV (EBR:OPTI) shareholders, since the share price has fallen 20% in that...
Reported Earnings • Oct 01First half earnings releasedOver the last 12 months the company has reported total losses of €5.41m, largely unchanged from the prior year. Total revenue was €18.3m over the last 12 months, up 3.2% from the prior year.